A patient with metastatic melanoma presenting with gastrointestinal perforation after dacarbazine infusion: a case report

por Oosting, Sjoukje F, Peters, Frans TM, Hospers, Geke AP, Mulder, Nanno H
Publicado 2010

Current and upcoming approaches to exploit the reversibility of epigenetic mutations in breast cancer

por Falahi, Fahimeh, van Kruchten, Michel, Martinet, Nadine, Hospers, Geke, Rots, Marianne G
Publicado 2014

Circulating Vascular Endothelial Growth Factor (VEGF) Levels in Advanced Stage Cancer Patients Compared to Normal Controls and Diabetes Mellitus Patients with Critical Ischemia

por Kusumanto, Yoka H., Meijer, Coby, Dam, Wendy, Mulder, Nanno H., Hospers, Geke A.P.
Publicado 2007

Gene specific overwriting of epigenetic signatures to modulate the expression of selected tumor-promoting genes in cancer

por Falahi, Fahimeh, Huisman, Christian, Diaz, Elisa Garcia, Kazemier, Hinke G, Hospers, Geke AP, Rots, Marianne G
Publicado 2013

Preoperative BRAF inhibition in patients with irresectable locally advanced stage III melanoma

por Faut, Marloes, Jalving, Mathilde, Diercks, Gilles F, Hospers, Geke A, van Leeuwen, Barbara L, Been, Lukas B
Publicado 2018

Retrospective Denial as A Coping Method

por Siemerink, Ester J. M., Jaspers, Jan P. C., Plukker, John T. M., Mulder, Nanno H., Hospers, Geke A. P.
Publicado 2011

Application of PET Tracers in Molecular Imaging for Breast Cancer

por Boers, Jorianne, de Vries, Erik F. J., Glaudemans, Andor W. J. M., Hospers, Geke A. P., Schröder, Carolina P.
Publicado 2020

OTHR-01. Unmet clinical needs in patients with brain metastases in the current treatment era

por Eggen, Annemarie C, Bosma, Ingeborg, Hiltermann, Thijo J N, Hospers, Geke A P, Reyners, Anna K L, Jalving, Mathilde
Publicado 2021

Anti-tumor treatment and healthcare consumption near death in the era of novel treatment options for patients with melanoma brain metastases

por Eggen, Annemarie C., Hospers, Geke A. P., Bosma, Ingeborg, Kramer, Miranda C. A., Reyners, Anna K. L., Jalving, Mathilde
Publicado 2022

Enhanced expression of PD-1 and other activation markers by CD4+ T cells of young but not old patients with metastatic melanoma

por van den Brom, Rob R. H., van der Geest, Kornelis S. M., Brouwer, Elisabeth, Hospers, Geke A. P., Boots, Annemieke M. H.
Publicado 2018

Image Quality and Interpretation of [(18)F]-FES-PET: Is There any Effect of Food Intake?

por Boers, Jorianne, Giatagana, Katerina, Schröder, Carolina P., Hospers, Geke A.P., de Vries, Erik F.J., Glaudemans, Andor W.J.M.
Publicado 2020

Re-Irradiation in Patients with Recurrent Rectal Cancer is Safe and Feasible

por Dijkstra, Esmée A., Mul, Véronique E. M., Hemmer, Patrick H. J., Havenga, Klaas, Hospers, Geke A. P., Muijs, Christina T., van Etten, Boudewijn
Publicado 2021

Molecular imaging as biomarker for treatment response and outcome in breast cancer

por van Geel, Jasper J. L., de Vries, Erik F. J., van Kruchten, Michel, Hospers, Geke A. P., Glaudemans, Andor W. J. M., Schröder, Carolina P.
Publicado 2023

Positron emission tomography of tumour [(18)F]fluoroestradiol uptake in patients with acquired hormone-resistant metastatic breast cancer prior to oestradiol therapy

por van Kruchten, Michel, Glaudemans, Andor W. J. M., de Vries, Erik F. J., Schröder, Carolien P., de Vries, Elisabeth G. E., Hospers, Geke A. P.
Publicado 2015

Value of screening and follow‐up brain MRI scans in patients with metastatic melanoma

por Eggen, Annemarie C., Wind, Thijs T., Bosma, Ingeborg, Kramer, Miranda C. A., van Laar, Peter Jan, van der Weide, Hiska L., Hospers, Geke A. P., Jalving, Mathilde
Publicado 2021

Mapping heterogeneity in glucose uptake in metastatic melanoma using quantitative (18)F-FDG PET/CT analysis

por de Heer, Ellen C., Brouwers, Adrienne H., Boellaard, Ronald, Sluiter, Wim J., Diercks, Gilles F. H., Hospers, Geke A. P., de Vries, Elisabeth G. E., Jalving, Mathilde
Publicado 2018

Effect of Extending the Original CROSS Criteria on Tumor Response to Neoadjuvant Chemoradiotherapy in Esophageal Cancer Patients: A National Multicenter Cohort Analysis

por Wang, Helena Hong, de Heer, Ellen C., Hulshoff, Jan Binne, Kats-Ugurlu, Gursah, Burgerhof, Johannes G. M., van Etten, Boudewijn, Plukker, John Th. M., Hospers, Geke A. P.
Publicado 2020

Rapid BRAF mutation tests in patients with advanced melanoma: comparison of immunohistochemistry, Droplet Digital PCR, and the Idylla Mutation Platform

por Bisschop, Cornelis, ter Elst, Arja, Bosman, Lisette J., Platteel, Inge, Jalving, Mathilde, van den Berg, Anke, Diepstra, Arjan, van Hemel, Bettien, Diercks, Gilles F.H., Hospers, Geke A.P., Schuuring, Ed
Publicado 2018

(18)F-BMS986192 PET Imaging of PD-L1 in Metastatic Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors: A Pilot Study

por Nienhuis, Pieter H., Antunes, Inês F., Glaudemans, Andor W.J.M., Jalving, Mathilde, Leung, David, Noordzij, Walter, Slart, Riemer H.J.A., de Vries, Erik F.J., Hospers, Geke A.P.
Publicado 2022

Clinical utility of circulating tumor DNA as a response and follow-up marker in cancer therapy

por Boonstra, Pieter A., Wind, Thijs T., van Kruchten, Michel, Schuuring, Ed, Hospers, Geke A. P., van der Wekken, Anthonie J., de Groot, Derk-Jan, Schröder, Carolien P., Fehrmann, Rudolf S. N., Reyners, Anna K. L.
Publicado 2020